Indo-MIM IPO 2026: GMP Today, Price Band, Subscription, Financials & Complete Review

The Indo-MIM IPO is one of the largest industrial manufacturing IPOs of 2026. The ₹3,811.21 crore mainboard issue opens for subscription from 23 July to 27 July 2026 and comprises a ₹499.10 crore fresh issue along with an Offer for Sale (OFS) worth ₹3,311.21 crore.

The company has fixed the Indo-MIM IPO price band at ₹461–₹485 per share, with a minimum lot size of 30 shares. Based on the latest grey market activity, the Indo-MIM IPO GMP today is ₹205, indicating an estimated listing price of around ₹690 per share.

In this article, you'll find complete details about the Indo-MIM IPO, including IPO dates, GMP, subscription status, company profile, financial performance, objectives of the issue, risks, valuation, and whether investors should consider applying.

Indo-MIM IPO Details

Indo-MIM IPO Timeline

Indo-MIM IPO GMP Today

As of 20 July 2026, the Indo-MIM IPO GMP today stands at ₹205 per share.

The GMP has shown a positive trend over the last few days, indicating strong interest in the grey market. However, GMP is unofficial and should not be the sole basis for an investment decision.

Indo-MIM IPO Day-wise GMP Trend

Indo-MIM IPO Live Subscription Status

The IPO opens for bidding on 23 July 2026.

We'll update the live subscription figures as soon as bidding begins.

Financial Performance

Indo-MIM has delivered strong growth over the last three years.

Key Ratios

• ROE: 21.26%
• ROCE: 26.60%
• PAT Margin: 12.72%
• EBITDA Margin: 25.54%
• Debt-to-Equity: 0.39

What is Indo-MIM? Leadership, Business Model & Manufacturing Network

Founded in 1996, Indo-MIM is one of the world's largest manufacturers of precision engineering components using Metal Injection Molding (MIM) technology. The Indo MIM company provides complete manufacturing solutions including mold design, tooling, precision machining, ceramic injection molding, investment casting, finishing, assembly, and advanced 3D metal printing.

The company manufactures over 6,400 products for industries such as automotive, medical, aerospace, defence, industrial engineering, and consumer electronics. Indo MIM aerospace components are supplied to global OEMs, while its defence business manufactures precision firearm components.
Headquartered near Hoskote, Bengaluru, the company operates 15 manufacturing facilities across India, the US, UK, and Mexico. Its Indian operations include facilities around Indo MIM Hoskote, Indo MIM Doddaballapur, Indo MIM Bangalore, Indo MIM Peenya, Indo MIM Devanahalli, Indo MIM Tirupati, and Indo MIM Pvt Ltd Chennai, giving it one of the largest global manufacturing footprints in the MIM industry.

Promoted by Green Meadows Investments Ltd., Krishna Chivukula, Krishna Chivukula Jr., Raj Chivukula, and Jagadamba Chandrasekhar, the company serves over 1,000 customers worldwide through sales offices in the US, Germany, China, and representatives across Europe and Asia.

Many investors searching for Indo MIM Pvt Ltd, Indo MIM company details, Indo MIM products, Indo MIM careers, Indo MIM salary, Indo MIM share price, Indo MIM Pvt Ltd Doddaballapur address, Indo MIM Bangalore Doddaballapur, or Indo US MIM Tec Pvt Ltd are researching the company ahead of its IPO.

Product Portfolio

Indo-MIM serves multiple industries through diversified products:

• Automotive components 
• Aerospace precision parts
• Medical devices and surgical instruments
• Defence firearm components
• Consumer electronics
• Industrial engineering components
• Investment cast products
• Ceramic injection molded components
• Precision machined parts
• 3D printed metal components

Competitive Strengths

• World's largest installed Metal Injection Molding (MIM) manufacturing capacity.
• Strong presence across automotive, aerospace, defence, and medical sectors.
• Diversified customer base with over 1,000 global clients.
• Backward integrated manufacturing operations.
• Export-driven business with global sales network.
• Strong R&D capabilities and advanced manufacturing technologies.
• Long-standing relationships with global OEMs.
• Experienced promoter and management team.

Objects of the Issue

The company plans to utilize the proceeds from the fresh issue for:

• Repayment or prepayment of outstanding borrowings (₹400 crore)
• General corporate purposes

Since a major portion of the IPO is an OFS, most proceeds from the OFS will go to the selling shareholders.

Risks

Investors should consider the following risks before investing:

• Export demand fluctuations.
• Dependence on global OEM customers.
• Raw material price volatility.
• High competition in precision engineering.
• Technology disruption in advanced manufacturing.
• Significant OFS component in the IPO.

Should You Invest in Indo-MIM IPO?

Indo-MIM operates in a niche manufacturing segment with global leadership in Metal Injection Molding technology. The company has a diversified customer base, strong export presence, robust financial growth, and healthy profitability.

The current Indo-MIM IPO indicates strong investor interest, but GMP alone should not drive investment decisions. Investors should also evaluate the valuation, peer comparison, long-term growth potential, and overall market conditions before applying.

For long-term investors looking for exposure to precision engineering and advanced manufacturing, Indo-MIM appears to be one of the notable industrial IPOs of 2026.

Looking to Invest Before the IPO?

If you're interested in investing in Indo-MIM unlisted shares before listing, you can check the latest unlisted share price, valuation, availability, and transaction process on UnlistedKraft once the stock becomes available.

Summary

The Indo-MIM IPO combines strong financial performance, global manufacturing leadership, and exposure to high-growth industries such as aerospace, defence, automotive, and healthcare. With a ₹3,811 crore issue size, healthy margins, expanding international presence, and a positive GMP trend, the IPO is likely to attract significant investor attention. Investors should monitor subscription data, valuation, and market sentiment before making an investment decision.

Frequently Asked Questions

What is the Indo-MIM IPO?

It is a mainboard IPO comprising a fresh issue of ₹499.10 crore and an OFS worth ₹3,311.21 crore.

What are the Indo-MIM IPO dates?

The IPO opens on 23 July 2026 and closes on 27 July 2026.

What is the Indo-MIM IPO price band?

The price band is ₹461–₹485 per share.

What is the Indo-MIM IPO GMP today?

The latest GMP is ₹205, indicating an estimated listing price of around ₹690.

What is the minimum investment?

Retail investors need to apply for 30 shares, requiring an investment of ₹14,550 at the upper price band.

Where will Indo-MIM shares be listed?

The shares are proposed to be listed on both BSE and NSE.

Sources

• Indo-MIM RHP
• NSE IPO Platform
• BSE IPO Updates
• Company Website
• MUFG Intime India Pvt. Ltd.
• Investkraft

Disclaimer

This article is for informational purposes only and should not be considered investment advice. Grey Market Premium (GMP) is unofficial and may change frequently. Investors should read the Red Herring Prospectus (RHP), evaluate the company's financials and valuation, and consult a qualified financial advisor before making any investment decision.

Author: Komal Bhatt

Komal Bhatt is a finance content writer at InvestKraft, specialising in well-researched articles on financial products, stock markets, and investment opportunities, with a particular focus on unlisted shares.

She holds a Master’s degree in Commerce from the University of Delhi, which gives her a solid academic foundation in finance and business. With over three years of hands-on experience in creating digital finance content, Komal has developed a clear understanding of investor needs through her work on wealth management, NISM certification programs, and market education materials.

Komal is passionate when it comes to breaking down complex financial concepts into simple, accurate and actionable insights. Her goal is to help everyday investors understand markets better and make more informed decisions based on reliable, research-backed information.